missing translation for 'onlineSavingsMsg'
Learn More
Learn More
IgG1[a] Mouse anti-Mouse, Brilliant Violet 650, Clone: 10.9, BD Optibuild™
Mouse Monoclonal Antibody
Marque: BD Biosciences 743262
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
This antibody is specific for mouse IgG1 of the Igh-C[a] /and the c, d, e, f, g, h, n, o, /and p /haplotypes (e.g. BALB/c, C58, A, AKR, CBA, C3H, DBA/1, DBA/2, NZB, SWR). It has been reported not to react with IgG1 of the Igh-C[b] /haplotype (e.g. C57BL/6, C57BL/10, SJL).
The antibody was conjugated to BD Horizon™ BV650 which is part of the BD Horizon Brilliant™ Violet family of dyes. This dye is a tandem fluorochrome of BD Horizon BV421 with an Ex Max of 405nm and an acceptor dye with an Em Max at 650nm. BD Horizon BV650 can be excited by the violet laser and detected in a filter used to detect APC-like dyes (eg, 660/20nm filter). Due to the excitation and emission characteristics of the acceptor dye, there will be spillover into the APC and Alexa Fluor™ 700 detectors. However, the spillover can be corrected through compensation as with any other dye combination. BV650 is a tandem fluorochrome of BD Horizon BV421 and an acceptor dye with an emission maximum at 650 nm. Due to the excitation and emission characteristics of the acceptor dye, there will be spillover into the APC and Alexa Fluor™ 700 detectors. BV650 will have moderate spillover into the BD Horizon™ BV711 detector.
Spécification
| IgG1[a] | |
| 10.9 | |
| Brilliant Violet 650 | |
| Igh-4a, Ighg1, IgG1 | |
| Not reported | |
| 50 μg | |
| Primary | |
| Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. |
| Monoclonal | |
| 0.2mg/mL | |
| Aqueous buffered solution containing ≤0.09% sodium azide. | |
| Mouse | |
| Affinity Purified | |
| RUO | |
| Mouse | |
| IgG2a κ |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu